Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rasim Gucalp, M.D.
Montefiore Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Healthalliance Hospitals
Fitchburg, Massachusetts, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Albert Einstein Cancer Center
The Bronx, New York, United States
- Jacobi Medical Center
The Bronx, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2004
- Primary completion
- 31 May 2007
- Completion
- 31 May 2007
- Last update posted
- 2 Aug 2018
- Registered enrollment
- 27
- Registry id
- NCT00200382
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.